Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis ameliorated by folate supplement

Jun Ichi Fukushi, Yasuharu Nakashima, Yukihide Iwamoto

研究成果: Contribution to journalArticle

1 引用 (Scopus)

抜粋

A 62-year-old male with a 10-year history of seropositive rheumatoid arthritis (RA) developed gynecomastia 8 months after beginning oral low-dose methotrexate (MTX) therapy. Two months after folate supplementation, the gynecomastia symptoms improved. Gynecomastia associated with low-dose MTX is a rare occurrence, with only nine cases previously reported in the literature. This is the first report showing folate supplementation to be effective against gynecomastia following low-dose MTX. Although it occurs infrequently, gynecomastia associated with low-dose MTX therapy should be considered in male patients with RA.

元の言語英語
ページ(範囲)1371-1372
ページ数2
ジャーナルRheumatology International
30
発行部数10
DOI
出版物ステータス出版済み - 8 1 2010

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

フィンガープリント Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis ameliorated by folate supplement' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用